Apply by September 1, 2027 for The Hope Foundation's Next Generation Fund—supporting workforce, education, and network-wide projects that strengthen SWOG's mission.

The work, “Federal and Industry Sponsorship in US Cancer Clinical Trials,” is published online August 20th by JAMA Oncology. The analysis found that, whereas industry trials were more likely to exami...

Email from The Hope Foundation for Cancer Research Join us on Bluesky and LinkedIn   August 19, 2026 National Make-A-Will Month: A Simple Step, A Lasting Impact A Reminder to Protect All You Love

Apply by September 1, 2027 for The Hope Foundation's Next Generation Fund—supporting workforce, education, and network-wide projects that strengthen SWOG's mission.

SWOG’s NCORP member sites are essential contributors in the group’s commitment to bring clinical trial opportunities to all patients affected by cancer and to ensure our trials enroll cohorts broadly ...

The Hope Foundation's 3rd annual Team Hope Ride at the 2026 Tour de Scottsdale.

After a national search chaired by our group statistician Dr. Mike LeBlanc, we have just selected Dr. Sonali M. Smith to be chair of SWOG’s lymphoma committee. Pending approval by the board of governo...

Email from The Hope Foundation for Cancer Research Help Us Reach the Finish Line   March 24, 2026 Help Team Hope Cross the Finish Line The Tour de Scottsdale Returns March 28 84 individual

FDA approved approved nivolumab (Opdivo, Bristol Myers Squibb Company) with doxorubicin, vinblastine, and dacarbazine (AVD) for cHL.

In our vision, SWOG’s next era of success grows from our current one. We’ll continue the group’s exemplary work as an NCTN leader in precision medicine, in the innovative study of rare cancers, and in...

Among academic journals, none has a higher journal impact factor than CA: A Cancer Journal for Clinicians, published by the American Cancer Society.